Literature DB >> 25700857

The economic burden of inpatients with type 2 diabetes: a case study in a Chinese hospital.

Hao Wang1, Xuan Lin2, Zhi Zhang2, Quan Wang1, Jun-Mei Chen2, Jing Liu2, Li Yuan3.   

Abstract

The purpose of this research was to study the components, influencing factors, and their changing trend in a Chinese hospital, so as to reduce the economic burden of inpatients with type 2 diabetes. Data were collected from 7487 cases. There were 4368 inpatients with type 2 diabetes during 2002-2012 in a Chinese hospital. Multivariate linear regression analysis was performed to explore the influencing factors of hospitalization costs. The number of inpatients and their hospitalization costs had increasing trends in the study period. The medicine, test, and examination charges were the main sources of total costs. Longer hospital stays, older ages, and more times of hospitalization led to higher medical costs. Actions should be taken on all fronts to control the rapidly increasing trend of hospitalization costs and to reduce hospital stays and the number of times of hospitalization to reduce the economic burden of diabetic inpatients.
© 2015 APJPH.

Entities:  

Keywords:  cost components; hospitalization costs; influencing factors; type 2 diabetes

Mesh:

Year:  2015        PMID: 25700857     DOI: 10.1177/1010539515572220

Source DB:  PubMed          Journal:  Asia Pac J Public Health        ISSN: 1010-5395            Impact factor:   1.399


  6 in total

1.  Diabetes awareness, treatment, control rates and associated risk factors among Beijing residents in 2011: A cross-sectional survey.

Authors:  Bao-Yu Feng; Chen Huang; Jie Cao; Zhong Dong; Fang-Chao Liu; Li-Nong Ji; Jin-Kui Yang; Gang Li; Jian-Xin Li; Xue-Li Yang; Jin Xie; Kai Fang; Jian-Feng Huang; Dong-Feng Gu
Journal:  Chronic Dis Transl Med       Date:  2016-12-15

2.  The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting.

Authors:  Jing Ma; Xu Wan; Bin Wu
Journal:  J Diabetes Res       Date:  2020-04-13       Impact factor: 4.011

3.  Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China.

Authors:  Xingyun Hou; Xu Wan; Bin Wu
Journal:  Front Pharmacol       Date:  2019-05-08       Impact factor: 5.810

4.  Cost-Effectiveness of Dipeptidylpeptidase-4 Inhibitors Added to Metformin in Patients With Type 2 Diabetes in China.

Authors:  Wen-Qiang Lin; Zhong-Jie Cai; Tingting Chen; Mao-Bai Liu; Na Li; Bin Zheng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-13       Impact factor: 5.555

5.  How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China.

Authors:  Haibin Wu; Karen N Eggleston; Jieming Zhong; Ruying Hu; Chunmei Wang; Kaixu Xie; Yiwei Chen; Xiangyu Chen; Min Yu
Journal:  BMJ Open       Date:  2018-11-01       Impact factor: 2.692

6.  Economic evaluation of dapagliflozin versus metformin in Chinese patients whose diabetes is inadequately controlled with diet and exercise.

Authors:  Hua Nian; Xu Wan; Jing Ma; Fu Jie; Bin Wu
Journal:  Cost Eff Resour Alloc       Date:  2020-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.